For the selected examples, KDM2B inhibited the growth, proliferation and metastasis of ovarian cancer,13 pancreatic cancer14 and bladder cancer.26 However, whether and how its activities might be modulated to facilitate tumour progression is still unclear. This evidence concerns the gene KDM2B and urinary bladder carcinoma.